Fulcrum Therapeutics Inc (FULC) Insider Trading
- $43,118,004.73
- $2,638,546.91
- March 8, 2024
- Robert J Gould
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 8, 2024 | VP | 4,884 | $11.72 | Sell | $57,240.48 | |
| May 10, 2023 | Insider | 210 | $3.31 | Sell | $695.10 | |
| Jan. 20, 2023 | Major Shareholder | 1,923,076 | $13.00 | Buy | $24,999,988.00 | |
| Jan. 13, 2023 | CEO | 6,766 | $15.00 | Sell | $101,490.00 | |
| Jan. 4, 2023 | Major Shareholder | 180,703 | $7.28 | Buy | $1,315,517.84 | |
| Dec. 27, 2022 | Major Shareholder | 4,089 | $5.99 | Buy | $24,493.11 | |
| Dec. 19, 2022 | Major Shareholder | 98,787 | $5.90 | Buy | $582,843.30 | |
| Dec. 16, 2022 | Major Shareholder | 1,341,420 | $5.42 | Buy | $7,270,496.40 | |
| Dec. 14, 2022 | Major Shareholder | 824,600 | $5.46 | Buy | $4,502,316.00 | |
| June 6, 2022 | Director | 24,382 | $8.10 | Sell | $197,494.20 | |
| June 3, 2022 | Director | 25,551 | $7.95 | Sell | $203,130.45 | |
| April 7, 2022 | Director | 5,631 | $24.02 | Sell | $135,256.62 | |
| April 4, 2022 | Director | 7,235 | $24.02 | Sell | $173,784.70 | |
| April 1, 2022 | Director | 34,464 | $24.03 | Sell | $828,169.92 | |
| June 28, 2021 | VP | 2,300 | $9.00 | Buy | $20,700.00 | |
| June 28, 2021 | Insider | 1,100 | $9.16 | Buy | $10,076.00 | |
| June 28, 2021 | SVP | 1,088 | $9.01 | Buy | $9,802.88 | |
| June 28, 2021 | Director | 10,000 | $9.16 | Buy | $91,600.00 | |
| March 15, 2021 | Insider | 9,211 | $12.13 | Sell | $111,729.43 | |
| Jan. 21, 2021 | VP | 6,607 | $14.00 | Sell | $92,498.00 | |
| Jan. 20, 2021 | Insider | 10,000 | $12.08 | Sell | $120,800.00 | |
| July 8, 2020 | Insider | 2,500 | $20.00 | Sell | $50,000.00 | |
| July 1, 2020 | SVP | 1,071 | $18.30 | Sell | $19,599.30 | |
| June 30, 2020 | Insider | 141 | $20.00 | Sell | $2,820.00 | |
| June 25, 2020 | SVP | 1,459 | $22.00 | Sell | $32,098.00 | |
| June 25, 2020 | Insider | 2,500 | $20.80 | Sell | $52,000.00 | |
| June 10, 2020 | SVP | 401 | $22.00 | Sell | $8,822.00 | |
| June 5, 2020 | SVP | 451 | $20.18 | Sell | $9,101.18 | |
| June 3, 2020 | Insider | 1,500 | $20.13 | Sell | $30,195.00 | |
| May 29, 2020 | SVP | 200 | $20.04 | Sell | $4,008.00 | |
| May 28, 2020 | Insider | 1,919 | $20.01 | Sell | $38,399.19 | |
| May 26, 2020 | Insider | 412 | $20.00 | Sell | $8,240.00 | |
| May 12, 2020 | SVP | 1,860 | $18.00 | Sell | $33,480.00 | |
| May 11, 2020 | VP | 7,500 | $16.00 | Sell | $120,000.00 | |
| March 2, 2020 | SVP | 2,143 | $17.38 | Sell | $37,245.34 | |
| Feb. 24, 2020 | VP | 5,000 | $16.83 | Sell | $84,150.00 | |
| Jan. 23, 2020 | VP | 5,000 | $17.22 | Sell | $86,100.00 | |
| July 22, 2019 | Major Shareholder | 118,750 | $16.00 | Buy | $1,900,000.00 | |
| July 22, 2019 | Director | 81,250 | $16.00 | Buy | $1,300,000.00 | |
| July 19, 2019 | Director | 61,280 | $17.79 | Buy | $1,090,171.20 |
Insiders are both buying and selling Fulcrum Therapeutics Inc stock.
The insider traders at Fulcrum Therapeutics Inc are: Robert J Gould, Diego Cadavid, Ra Capital Management, L.P., Peter G Thomson, Greg Tourangeau, Owen B Wallace, Robert J. Gould, 6 Dimensions Capital, L.P., Rock Ventures Iii L.P. Third, Christopher Morabito, Curtis Gale Oltmans, James A Geraghty, Mark J Levin, and Peter G. Thomson
The most active insider trader at Fulcrum Therapeutics Inc is Robert J Gould with 11 trades.
Robert J Gould has sold the most Fulcrum Therapeutics Inc stock with a total value of $2,008,682.89.
Ra Capital Management, L.P. has bought the most Fulcrum Therapeutics Inc stock with a total value of $63,695,642.65.
The most recent insider trade for Fulcrum Therapeutics Inc was on March 8, 2024.
The single biggest insider buy for Fulcrum Therapeutics Inc was from Ra Capital Management, L.P. with a total value of $24,999,988.00 on Jan. 20, 2023.
The single biggest insider sell for Fulcrum Therapeutics Inc was from Robert J Gould with a total value of $828,169.92 on April 1, 2022.